Availability and use of Standards in vaccine development Article Swipe
Michael S. Avumegah
,
Giada Mattiuzzo
,
Anna Särnefält
,
Mark Page
,
Karen W. Makar
,
Janet Lathey
,
June Myung Kim
,
Solomon Abebe Yimer
,
Danielle Craig
,
Ivana Knežević
,
Valentina Bernasconi
,
Paul A. Kristiansen
,
Ingrid Kromann
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1038/s41541-023-00692-0
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1038/s41541-023-00692-0
Related Topics
Concepts
Coronavirus disease 2019 (COVID-19)
Manufacturing process
Risk analysis (engineering)
Computer science
Medicine
Disease
Infectious disease (medical specialty)
Materials science
Composite material
Pathology
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41541-023-00692-0
- https://www.nature.com/articles/s41541-023-00692-0.pdf
- OA Status
- gold
- Cited By
- 11
- References
- 16
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4382777218
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4382777218Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41541-023-00692-0Digital Object Identifier
- Title
-
Availability and use of Standards in vaccine developmentWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-06-30Full publication date if available
- Authors
-
Michael S. Avumegah, Giada Mattiuzzo, Anna Särnefält, Mark Page, Karen W. Makar, Janet Lathey, June Myung Kim, Solomon Abebe Yimer, Danielle Craig, Ivana Knežević, Valentina Bernasconi, Paul A. Kristiansen, Ingrid KromannList of authors in order
- Landing page
-
https://doi.org/10.1038/s41541-023-00692-0Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s41541-023-00692-0.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41541-023-00692-0.pdfDirect OA link when available
- Concepts
-
Coronavirus disease 2019 (COVID-19), Manufacturing process, Risk analysis (engineering), Computer science, Medicine, Disease, Infectious disease (medical specialty), Materials science, Composite material, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
11Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 7Per-year citation counts (last 5 years)
- References (count)
-
16Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4382777218 |
|---|---|
| doi | https://doi.org/10.1038/s41541-023-00692-0 |
| ids.doi | https://doi.org/10.1038/s41541-023-00692-0 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37391580 |
| ids.openalex | https://openalex.org/W4382777218 |
| fwci | 3.09842124 |
| type | review |
| title | Availability and use of Standards in vaccine development |
| biblio.issue | 1 |
| biblio.volume | 8 |
| biblio.last_page | 95 |
| biblio.first_page | 95 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9991999864578247 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T12576 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.996399998664856 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | vaccines and immunoinformatics approaches |
| topics[2].id | https://openalex.org/T11754 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9929999709129333 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | SARS-CoV-2 detection and testing |
| is_xpac | False |
| apc_list.value | 3170 |
| apc_list.currency | USD |
| apc_list.value_usd | 3170 |
| apc_paid.value | 3170 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3170 |
| concepts[0].id | https://openalex.org/C3008058167 |
| concepts[0].level | 4 |
| concepts[0].score | 0.49003899097442627 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[0].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[1].id | https://openalex.org/C2987875673 |
| concepts[1].level | 2 |
| concepts[1].score | 0.42788949608802795 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q187939 |
| concepts[1].display_name | Manufacturing process |
| concepts[2].id | https://openalex.org/C112930515 |
| concepts[2].level | 1 |
| concepts[2].score | 0.40191909670829773 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4389547 |
| concepts[2].display_name | Risk analysis (engineering) |
| concepts[3].id | https://openalex.org/C41008148 |
| concepts[3].level | 0 |
| concepts[3].score | 0.3966452479362488 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[3].display_name | Computer science |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.3471425771713257 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C2779134260 |
| concepts[5].level | 2 |
| concepts[5].score | 0.0 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[5].display_name | Disease |
| concepts[6].id | https://openalex.org/C524204448 |
| concepts[6].level | 3 |
| concepts[6].score | 0.0 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[6].display_name | Infectious disease (medical specialty) |
| concepts[7].id | https://openalex.org/C192562407 |
| concepts[7].level | 0 |
| concepts[7].score | 0.0 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[7].display_name | Materials science |
| concepts[8].id | https://openalex.org/C159985019 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q181790 |
| concepts[8].display_name | Composite material |
| concepts[9].id | https://openalex.org/C142724271 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[9].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[0].score | 0.49003899097442627 |
| keywords[0].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[1].id | https://openalex.org/keywords/manufacturing-process |
| keywords[1].score | 0.42788949608802795 |
| keywords[1].display_name | Manufacturing process |
| keywords[2].id | https://openalex.org/keywords/risk-analysis |
| keywords[2].score | 0.40191909670829773 |
| keywords[2].display_name | Risk analysis (engineering) |
| keywords[3].id | https://openalex.org/keywords/computer-science |
| keywords[3].score | 0.3966452479362488 |
| keywords[3].display_name | Computer science |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.3471425771713257 |
| keywords[4].display_name | Medicine |
| language | en |
| locations[0].id | doi:10.1038/s41541-023-00692-0 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210235625 |
| locations[0].source.issn | 2059-0105 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2059-0105 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | npj Vaccines |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s41541-023-00692-0.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | npj Vaccines |
| locations[0].landing_page_url | https://doi.org/10.1038/s41541-023-00692-0 |
| locations[1].id | pmid:37391580 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | NPJ vaccines |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37391580 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10313826 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10313826/pdf/41541_2023_Article_692.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | NPJ Vaccines |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10313826 |
| locations[3].id | pmh:oai:doaj.org/article:85e4e74bb8474aaa870c55b40fa447c9 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | npj Vaccines, Vol 8, Iss 1, Pp 1-5 (2023) |
| locations[3].landing_page_url | https://doaj.org/article/85e4e74bb8474aaa870c55b40fa447c9 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5090943299 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2325-2238 |
| authorships[0].author.display_name | Michael S. Avumegah |
| authorships[0].countries | NO |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[0].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[0].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[0].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[0].institutions[0].country_code | NO |
| authorships[0].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Michael Selorm Avumegah |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[1].author.id | https://openalex.org/A5025561786 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9475-1590 |
| authorships[1].author.display_name | Giada Mattiuzzo |
| authorships[1].affiliations[0].raw_affiliation_string | Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, UK |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Giada Mattiuzzo |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, UK |
| authorships[2].author.id | https://openalex.org/A5111001774 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Anna Särnefält |
| authorships[2].countries | NO |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[2].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[2].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[2].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[2].institutions[0].country_code | NO |
| authorships[2].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Anna Särnefält |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[3].author.id | https://openalex.org/A5013541619 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8664-133X |
| authorships[3].author.display_name | Mark Page |
| authorships[3].affiliations[0].raw_affiliation_string | Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, UK |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mark Page |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, UK |
| authorships[4].author.id | https://openalex.org/A5014477842 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Karen W. Makar |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1303444417 |
| authorships[4].affiliations[0].raw_affiliation_string | Bill & Melinda Gates Foundation (BMGF), Seattle, USA |
| authorships[4].institutions[0].id | https://openalex.org/I1303444417 |
| authorships[4].institutions[0].ror | https://ror.org/0456r8d26 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I1303444417 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Gates Foundation |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Karen Makar |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Bill & Melinda Gates Foundation (BMGF), Seattle, USA |
| authorships[5].author.id | https://openalex.org/A5092373702 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Janet Lathey |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210134534 |
| authorships[5].affiliations[0].raw_affiliation_string | National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[5].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Janet Lathey |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, USA |
| authorships[6].author.id | https://openalex.org/A5041277249 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0337-8573 |
| authorships[6].author.display_name | June Myung Kim |
| authorships[6].countries | NO |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[6].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[6].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[6].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[6].institutions[0].country_code | NO |
| authorships[6].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | June Kim |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[7].author.id | https://openalex.org/A5038726427 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0959-3052 |
| authorships[7].author.display_name | Solomon Abebe Yimer |
| authorships[7].countries | NO |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[7].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[7].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[7].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[7].institutions[0].country_code | NO |
| authorships[7].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Solomon Abebe Yimer |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[8].author.id | https://openalex.org/A5027623266 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Danielle Craig |
| authorships[8].countries | NO |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[8].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[8].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[8].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[8].institutions[0].country_code | NO |
| authorships[8].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Danielle Craig |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[9].author.id | https://openalex.org/A5041055387 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6441-7601 |
| authorships[9].author.display_name | Ivana Knežević |
| authorships[9].countries | CH |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210105654 |
| authorships[9].affiliations[0].raw_affiliation_string | World Health Organization (WHO), Geneva, Switzerland |
| authorships[9].institutions[0].id | https://openalex.org/I4210105654 |
| authorships[9].institutions[0].ror | https://ror.org/01f80g185 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210105654 |
| authorships[9].institutions[0].country_code | CH |
| authorships[9].institutions[0].display_name | World Health Organization |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Ivana Knezevic |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | World Health Organization (WHO), Geneva, Switzerland |
| authorships[10].author.id | https://openalex.org/A5030823631 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8357-6838 |
| authorships[10].author.display_name | Valentina Bernasconi |
| authorships[10].countries | NO |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[10].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[10].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[10].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[10].institutions[0].country_code | NO |
| authorships[10].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Valentina Bernasconi |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[11].author.id | https://openalex.org/A5102833793 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-3112-763X |
| authorships[11].author.display_name | Paul A. Kristiansen |
| authorships[11].countries | NO |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[11].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[11].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[11].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[11].institutions[0].type | facility |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[11].institutions[0].country_code | NO |
| authorships[11].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Paul A. Kristiansen |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[12].author.id | https://openalex.org/A5080578571 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-6244-8332 |
| authorships[12].author.display_name | Ingrid Kromann |
| authorships[12].countries | NO |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210118009 |
| authorships[12].affiliations[0].raw_affiliation_string | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| authorships[12].institutions[0].id | https://openalex.org/I4210118009 |
| authorships[12].institutions[0].ror | https://ror.org/02j9wvt50 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210118009 |
| authorships[12].institutions[0].country_code | NO |
| authorships[12].institutions[0].display_name | Coalition for Epidemic Preparedness Innovations |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Ingrid Kromann |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41541-023-00692-0.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Availability and use of Standards in vaccine development |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9991999864578247 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W2775453485, https://openalex.org/W3033830313, https://openalex.org/W3017076641, https://openalex.org/W175616201, https://openalex.org/W2254699830, https://openalex.org/W1563935346, https://openalex.org/W4224261634, https://openalex.org/W2399727033 |
| cited_by_count | 11 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 7 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1038/s41541-023-00692-0 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210235625 |
| best_oa_location.source.issn | 2059-0105 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2059-0105 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | npj Vaccines |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41541-023-00692-0.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | npj Vaccines |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41541-023-00692-0 |
| primary_location.id | doi:10.1038/s41541-023-00692-0 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210235625 |
| primary_location.source.issn | 2059-0105 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2059-0105 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | npj Vaccines |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s41541-023-00692-0.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | npj Vaccines |
| primary_location.landing_page_url | https://doi.org/10.1038/s41541-023-00692-0 |
| publication_date | 2023-06-30 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3081062975, https://openalex.org/W4205101349, https://openalex.org/W4285009782, https://openalex.org/W2990745657, https://openalex.org/W1976699577, https://openalex.org/W3211284609, https://openalex.org/W2979324456, https://openalex.org/W3164547793, https://openalex.org/W4220905041, https://openalex.org/W3182870240, https://openalex.org/W3212447088, https://openalex.org/W3171486494, https://openalex.org/W4295454078, https://openalex.org/W4221117868, https://openalex.org/W4225318148, https://openalex.org/W4225470021 |
| referenced_works_count | 16 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5090943299 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 13 |
| corresponding_institution_ids | https://openalex.org/I4210118009 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5099999904632568 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.89446984 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |